← Evidence map

ArticleFrontiers in oncology2023

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36865793